BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20280312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20281105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270127
DTEND;VALUE=DATE:20270130
DTSTAMP:20260714T084502Z
CREATED:20260710T124647Z
LAST-MODIFIED:20260714T084502Z
UID:100123128-1801008000-1801267199@www.pathologynews.com
SUMMARY:Precision Medicine World Conference 2027
DESCRIPTION:0000Days00Hrs00Min00SecThe Davos of Precision Medicine. Driving the future of patient care.\nPMWC\, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders\, top global researchers and medical professionals\, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors\, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine. \nSince 2009\, recognized as a vital cornerstone for all constituents of the health care and biotechnology community\, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology)\, in clinical implementation (e.g. cancer and beyond)\, research\, and in all aspects related to the regulatory and reimbursement sectors. \nRegister Now
URL:https://www.pathologynews.com/event/precision-medicine-world-conference-2027/
LOCATION:Santa Clara Convention Center\, 5001 Great America Pkwy\, Santa Clara\, CA\, 95054\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/Precision-Medicine-World-Conference-2027.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261216
DTEND;VALUE=DATE:20261219
DTSTAMP:20260910T135726Z
CREATED:20260910T135726Z
LAST-MODIFIED:20260910T135726Z
UID:100124769-1797379200-1797638399@www.pathologynews.com
SUMMARY:Congresso Annuale di Anatomia Patologica 2026 SIAPeC-IAP
DESCRIPTION:0000Days00Hrs00Min00SecINNOVAZIONE\, CONSERVAZIONE\, PREDIZIONE\ntre parole chiave che sintetizzano il profondo cambiamento in atto nell’Anatomia Patologica. \nÈ giunto il tempo che la nostra disciplina\, pietra angolare del processo diagnostico-terapeutico\, affronti con decisione le sfide dell’automazione e della digitalizzazione\, orientandosi verso un utilizzo consapevole e responsabile dell’Intelligenza Artificiale. Siamo chiamati a un passaggio cruciale: integrare automazione e digitalizzazione senza disperdere il valore della nostra esperienza\, e governare l’Intelligenza Artificiale affinché sia uno strumento al servizio del pensiero clinico\, non il suo sostituto. \nIn questo scenario\, l’Anatomia Patologica è destinata a diventare ancora più centrale: non solo luogo della diagnosi\, ma snodo essenziale per la predizione e la personalizzazione delle cure. Centrale il tema della conservazione del materiale istologico\, condizione necessaria per garantire ai cittadini l’accesso alle terapie di oggi e di domani. \nRegister Now
URL:https://www.pathologynews.com/event/congresso-annuale-di-anatomia-patologica-2026-siapec-iap/
LOCATION:CENTRO CONGRESSI LINGOTTO\, Via Nizza\, 280\, Torino\, 10126\, Italy
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/Congresso-Annuale-di-Anatomia-Patologica-2026-SIAPeC-IAP.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261210
DTEND;VALUE=DATE:20261213
DTSTAMP:20260922T152310Z
CREATED:20260922T152310Z
LAST-MODIFIED:20260922T152310Z
UID:100125381-1796860800-1797119999@www.pathologynews.com
SUMMARY:Inside the Digital Lab: Michigan Medicine ​
DESCRIPTION:0000Days00Hrs00Min00SecAPI’s 2026 fall meeting celebrates its 10th year with a new name: Inside the Digital Lab (IDL)\, formerly the Digital Pathology-AI (DP-AI) Workshop. The event offers a behind-the-scenes look at institutions that have successfully implemented the latest technologies\, AI solutions and innovative workflow approaches. \nIDL is a roving meeting featuring on-site laboratory tours alongside tailored\, site-specific programming. In 2026\, the meeting will be hosted by Michigan Medicine in Ann Arbor\, Michigan\, showcasing its journey towards a comprehensive digital workflow for primary diagnosis in Anatomic Pathology. \nThe hands-on programme will also include opportunities to explore solutions from participating vendors\, alongside presentations of comparative use cases designed to encourage knowledge exchange and highlight new possibilities for healthcare systems worldwide. \nRegister Now
URL:https://www.pathologynews.com/event/inside-the-digital-lab-michigan-medicine/
LOCATION:University of Michigan\, Ann Arbor\, MI\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/Inside-the-Digital-Lab-Michigan-Medicine.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261209
DTEND;VALUE=DATE:20261211
DTSTAMP:20260923T144036Z
CREATED:20260108T163108Z
LAST-MODIFIED:20260923T144036Z
UID:100117774-1796774400-1796947199@www.pathologynews.com
SUMMARY:Digital Pathology and AI Congress: Europe 2026
DESCRIPTION:0000Days00Hrs00Min00SecThis internationally recognised meeting brings together 600+ attendees and 60+ technology providers to discuss and collaborate on the latest advances\, developments and case studies in the Digital Pathology & AI field. As digital workflows become the norm\, the focus now turns to refining digital workflows and how the future of Digital Pathology & AI may lead us to precision medicine approaches for disease treatment. \nAs a part of the 2025 meeting\, attendees discovered how to overcome potential challenges with LIMS and digital workflows\, learned about Digital Pathology and AI integration in clinical trials and found out about the return on investment when implementing Digital Pathology.  Plus\, we explored AI regulation and the ethics of using the technology. \nAt the heart of our conference lies an unparalleled opportunity to connect. With over seven hours dedicated exclusively to networking\, participants have the time and space to engage deeply with peers\, share ideas\, and spark meaningful collaborations. These interactions are where breakthroughs begin — fostering connections that drive collaborative innovation and discovery. \nRegister Now\nRegister and use discount code\nPN2026\nto receive 20% off your registration.
URL:https://www.pathologynews.com/event/digital-pathology-and-ai-congress-europe-2026/
LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Digital-Pathology-and-AI-Congress-Europe-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261208
DTEND;VALUE=DATE:20261212
DTSTAMP:20260918T091129Z
CREATED:20260918T091129Z
LAST-MODIFIED:20260918T091129Z
UID:100125226-1796688000-1797033599@www.pathologynews.com
SUMMARY:San Antonio Breast Cancer Symposium® 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe largest breast cancer research symposium in the world.\nGoals of the Symposium\nThe San Antonio Breast Cancer Symposium® is designed to provide state-of-the-art information on the experimental biology\, etiology\, prevention\, diagnosis\, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers. \nThe scientific program consists of formal lectures by experts in clinical\, translational\, and basic research; selected slide and poster presentations; forums; and case discussions. The official language of the symposium is English. Simultaneous translation is not provided. \nTarget Audience\nThis international Symposium is directed primarily toward academic and private physicians and researchers involved in breast cancer in medical\, surgical\, gynecologic\, and radiation oncology\, as well as patient advocates and other appropriate health care professionals. SABCS expects over 10\,000 attendees from more than 105 countries will attend in 2026. \nRegister Now
URL:https://www.pathologynews.com/event/san-antonio-breast-cancer-symposium-2026/
LOCATION:Henry B. Gonzalez Convention Center\, San Antonio\, TX\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/San-Antonio-Breast-Cancer-Symposium®-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261129
DTEND;VALUE=DATE:20261204
DTSTAMP:20260922T132157Z
CREATED:20260922T132157Z
LAST-MODIFIED:20260922T132157Z
UID:100125349-1795910400-1796342399@www.pathologynews.com
SUMMARY:RSNA Annual Meeting 2026
DESCRIPTION:0000Days00Hrs00Min00Sec\n  \n\n\n\n\n\n\n\n\nRSNA 2026 brings together the global radiology community to explore the latest advances in medical imaging\, technology and patient care. The annual meeting combines cutting-edge research\, expert-led education\, technological innovation and networking\, with a strong focus on the evolving role of radiology in modern healthcare. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nKey topics\n\nArtificial intelligence and AI-enabled imaging\nAdvances in diagnostic and interventional radiology\nMedical imaging technologies and innovation\nPersonalised and patient-centred care\nImaging research and emerging clinical applications\nQuality improvement and clinical practice\nData\, digital tools and imaging informatics\n\n\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/rsna-annual-meeting-2026/
LOCATION:Chicago\, 2301 S Martin Luther King Dr\, Chicago\, IL\, IL 60616\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/RSNA-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261129
DTSTAMP:20260910T133711Z
CREATED:20260617T103209Z
LAST-MODIFIED:20260910T133711Z
UID:100122189-1795737600-1795910399@www.pathologynews.com
SUMMARY:9th Annual Meeting: Association of Breast Pathology
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\nIt’s a great opportunity to learn from experts\, share experiences and connect with colleagues from across the field.\n\n\n\n\n\n\n\n\n\n\nJoin the Association of Breast Pathology for one and a half days of engaging talks\, practical lectures\, case-based discussions and the latest updates in breast pathology. \n\n\n\n\n\nProgramme Highlights\n\nWHO guidelines update\nUpdate on fibroepithelial lesions\nHow to score Ki-67\nTriple negative and ER-low breast cancer\nEveryday dilemmas in breast pathology\nand much more…\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/9th-annual-meeting-association-of-breast-pathology/
LOCATION:The Royal Society of Medicine\, 1 Wimpole St\, London\, W1G 0AE\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/06/9TH-ANNUAL-MEETING-ASSOCIATION-OF-BREAST-PATHOLOGY.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261123
DTSTAMP:20260914T100546Z
CREATED:20260914T100546Z
LAST-MODIFIED:20260914T100546Z
UID:100124953-1795046400-1795391999@www.pathologynews.com
SUMMARY:ASDP 63rd Annual Meeting
DESCRIPTION:0000Days00Hrs00Min00SecThe American Society of Dermatopathology (ASDP) 63rd Annual Meeting will bring together the dermatopathology community for a comprehensive programme of education\, scientific exchange and networking. \nThe meeting will feature plenary sessions and courses\, oral abstract presentations and poster sessions\, alongside opportunities for attendees to connect with colleagues from across the field. Optional virtual Interactive Microscopy sessions and Dermatopathology Seminars will take place ahead of the main meeting. \nAttendees can participate in person or virtually\, with the main programme live-streamed for online participants. Registered attendees will also have on-demand access to recorded Plenary Programme sessions and courses until 30 April 2027. \nRegister Now
URL:https://www.pathologynews.com/event/asdp-63rd-annual-meeting/
LOCATION:Omni Atlanta Hotel at Centennial Park\, Atlanta\, GA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/ASDP-63rd-Annual-Meeting.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261121
DTSTAMP:20260923T131928Z
CREATED:20260923T131928Z
LAST-MODIFIED:20260923T131928Z
UID:100125455-1795046400-1795219199@www.pathologynews.com
SUMMARY:AI & Digital Pathology Summit 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe AI & Digital Pathology Summit brings together pathologists\, researchers\, healthcare professionals and industry experts to explore advances in artificial intelligence and digital pathology. The programme combines an AI masterclass with a showcase focused on the real-world deployment and clinical implementation of digital and AI-driven pathology solutions. \nKey topics\n\nArtificial intelligence and machine learning in pathology\nDeep learning for pathology image analysis\nDigital pathology implementation and clinical adoption\nReal-world deployment of AI tools\nData collection\, annotation and model development\nExplainable and trustworthy AI\nComputational pathology research\nAI integration into daily pathology practice\nAutomated imaging and cell classification\nEmerging trends in digital and AI-driven pathology\n\nRegister Now
URL:https://www.pathologynews.com/event/ai-digital-pathology-summit-2026/
LOCATION:Porto\, Porto\, Portugal
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/AI-Digital-Pathology-Summit-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261118
DTEND;VALUE=DATE:20261121
DTSTAMP:20260910T110338Z
CREATED:20260910T110338Z
LAST-MODIFIED:20260910T110338Z
UID:100124735-1794960000-1795219199@www.pathologynews.com
SUMMARY:Carrefour Pathologie 2026
DESCRIPTION:0000Days00Hrs00Min00SecOrganised by the French Society of Pathology (SFP)\, Carrefour Pathologie 2026 will bring together the French-speaking pathology community for three days of scientific education\, discussion and networking. \nThe scientific programme will feature: \n\nThree histoseminars covering the reactive lymph node\, developments in non-tumour oesophageal pathology and the tumour kidney.\nSFP conferences exploring AI for pathology diagnosis\, forensic expertise in anatomy and cytology\, and the new WHO classification in gynaecopathology.\nSymposia on pancreatic and bile duct cytology\, eco-responsibility and eco-design of care\, and new network labelling.\nAn interactive session focusing on biopsies in ENT pathology.\nA new “Controversy” session discussing remote working in pathology.\nFrench Society of Clinical Cytology (SFCC) sessions covering AI in urinary cytology and pulmonary cytology.\nAn AFAQAP session addressing medical error for pathologists.\nINSERM conferences exploring organoids and xenografts.\n“Flash” sessions on liquid biopsies and the new WHO classification of brain tumours.\nMedico-technical sessions covering technicians and digital pathology\, as well as training and accreditation.\nThe AIP day\, dedicated to neuroendocrine tumours.\n\nRegister Now
URL:https://www.pathologynews.com/event/carrefour-pathologie-2026/
LOCATION:CNIT Forest in Paris la Défense\, 2 Le PARV de la Défense\, Paris\, 92800\, France
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/Carrefour-Pathologie-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261117
DTEND;VALUE=DATE:20261121
DTSTAMP:20260922T135940Z
CREATED:20260922T135940Z
LAST-MODIFIED:20260922T135940Z
UID:100125372-1794873600-1795219199@www.pathologynews.com
SUMMARY:ASCP | CAP-ACP Annual Meeting 2026
DESCRIPTION:0000Days00Hrs00Min00SecScience is a process of moving forward\, creating new steps brick by brick. The work is steady\, always advancing towards new discoveries and knowledge. And none of it happens in a vacuum. Individuals come together and make their own contributions\, culminating in the latest in laboratory advancements. \nThe 2026 Annual Meeting\, hosted by ASCP and the Canadian Association of Pathologists (CAP-ACP)\, creates an environment of learning where the entire laboratory team can come together and build the road towards the future. More than a learning event\, the 2026 Annual Meeting is where you have the opportunity to connect with colleagues new and old\, coming together to solve the pressing issues of the laboratory. \nKey topics\n\nAnatomic and clinical pathology\nSurgical pathology and cytopathology\nHaematopathology and transfusion medicine\nDigital and computational pathology\nArtificial intelligence and large language models\nPrecision diagnostics and biomarker testing\nPathology informatics\nLaboratory management and leadership\nQuality improvement and patient safety\nTest utilisation and public policy\nWorkforce\, workload and wellbeing\nEmerging diagnostic techniques and laboratory innovation\n\nRegister Now
URL:https://www.pathologynews.com/event/ascp-cap-acp-annual-meeting-2026/
LOCATION:Palais des congrès de Montréal\, 159\, rue Saint-Antoine Ouest\, Montreal\, Quebec\, H2Z 1H2\, Canada
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/ASCP-CAP-ACP-Annual-Meeting-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20260918T085537Z
CREATED:20260918T085537Z
LAST-MODIFIED:20260918T085537Z
UID:100125210-1794787200-1795046399@www.pathologynews.com
SUMMARY:ESMO AI & Digital Oncology Congress 2026
DESCRIPTION:0000Days00Hrs00Min00SecBringing together healthcare and digital health experts from around the world\, it fosters collaboration\, inspires learning and empowers oncology professionals to stay ahead in the digital transformation of medicine. \nKey Topics and Highlights\n\nLatest advances in AI and digital technologies in oncology\nDigital pathology and AI-driven image analysis\nAI-powered biomarkers and precision oncology\nIntegration of imaging\, genomics\, pathology and clinical data\nAI applications in clinical research and early-phase trials\nDigital tools supporting clinical decision-making and personalised treatment\nOpportunities and challenges of implementing AI in real-world cancer care\nExpert insights into the clinical\, ethical and practical considerations surrounding AI adoption\nNetworking and knowledge exchange with the international oncology and digital health community\n\nThese themes align with ESMO’s current focus on AI in oncology\, including multimodal biomarkers\, digital pathology\, clinical decision support and AI applications in cancer research. \nRegister Now
URL:https://www.pathologynews.com/event/esmo-ai-digital-oncology-congress-2026/
LOCATION:CityCube – Messe Berlin\, Berlin\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/ESMO-AI-Digital-Oncology-Congress-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261110
DTEND;VALUE=DATE:20261115
DTSTAMP:20260916T092527Z
CREATED:20260916T092527Z
LAST-MODIFIED:20260916T092527Z
UID:100125054-1794268800-1794700799@www.pathologynews.com
SUMMARY:AMP Annual Meeting & Expo 26
DESCRIPTION:0000Days00Hrs00Min00SecThe AMP 2026 Annual Meeting & Expo\, organised by the Association for Molecular Pathology\, will bring together professionals from across the molecular diagnostics community to explore the latest advances shaping molecular pathology and precision medicine. The programme combines scientific and educational sessions\, plenary lectures\, case studies\, poster presentations\, corporate workshops and an extensive exhibition. \nKey areas and activities include:\n\nGenetics and genomics\nMolecular oncology and solid tumours\nHematopathology\nInfectious disease diagnostics\nBioinformatics and informatics\nEmerging technologies and molecular diagnostic methods\nBiomarker testing and precision medicine\nNGS bioinformatics\nCytology specimens and molecular testing\n\nThe meeting is designed for pathologists\, clinical and research scientists\, laboratory professionals\, educators and trainees working across diagnostic\, prognostic and therapeutic applications of molecular pathology. \nRegister Now
URL:https://www.pathologynews.com/event/amp-annual-meeting-expo-26/
LOCATION:Seattle Convention Center\, Seattle\, WA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/AMP-Annual-Meeting-Expo-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261105
DTEND;VALUE=DATE:20261110
DTSTAMP:20260916T095046Z
CREATED:20260916T095046Z
LAST-MODIFIED:20260916T095046Z
UID:100125064-1793836800-1794268799@www.pathologynews.com
SUMMARY:AASLD The Liver Meeting 2026
DESCRIPTION:0000Days00Hrs00Min00SecOrganised by the American Association for the Study of Liver Diseases (AASLD)\, The Liver Meeting 2026 brings together the global hepatology community to share the latest research\, clinical developments and innovations shaping the future of liver health. The programme spans basic and translational science\, clinical practice and emerging technologies\, alongside extensive opportunities for education and networking. \nKey topics and activities include:\n\nMASLD and MASH\, including emerging treatments and management of associated conditions\nAlcohol-associated liver disease and MetALD\nHepatocellular carcinoma (HCC)\, including early detection\, diagnostics and new treatment approaches\nViral hepatitis and cholestatic liver disease\nAI and machine learning in liver care and diagnostics\nGenomics and precision medicine\nLiver transplantation and surgery\nPortal hypertension and cirrhosis management\nBasic and translational liver research\n\nThe meeting provides a forum for hepatologists\, pathologists\, researchers\, clinicians\, trainees and multidisciplinary teams to exchange knowledge and explore advances in the prevention\, diagnosis and treatment of liver disease. \nRegister Now
URL:https://www.pathologynews.com/event/aasld-the-liver-meeting-2026/
LOCATION:Colorado Convention Center\, Denver\, CO\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/09/AASLD-The-Liver-Meeting-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T160000
DTEND;TZID=Europe/London:20261104T170000
DTSTAMP:20261002T090317Z
CREATED:20261002T090317Z
LAST-MODIFIED:20261002T090317Z
UID:100125902-1793808000-1793811600@www.pathologynews.com
SUMMARY:Open AI Workflows in Digital Pathology: Model Interoperability with HALO®
DESCRIPTION:Learn About AI Model Interoperability with HALO AI\n\n  \n\nSummary\n\n\n\n\nAs artificial intelligence becomes increasingly integrated into digital pathology\, interoperability between image analysis platforms\, externally developed models\, and custom computational workflows is becoming increasingly important. This webinar will demonstrate multiple approaches for integrating AI models with HALO®\, highlighting how users can move models into\, out of\, and alongside the HALO ecosystem.  \nFirst\, we will demonstrate how externally developed models can be imported into HALO using the ONNX standard\, allowing models created in external machine learning environments to be incorporated into HALO-based analysis workflows. Next\, we will show how a model developed using HALO AI can be exported to ONNX and used for inference in an external Python workflow\, illustrating how HALO-trained models can be extended beyond the platform.  \nFinally\, we will demonstrate a service-based integration in which a custom AI model is deployed in a Docker container and connected to HALO through the HALO API. This approach enables models to remain within their native software environment while still participating in HALO-driven analysis workflows.  \nTogether\, these examples illustrate different levels of model portability and workflow interoperability\, providing flexible options for integrating open-source\, internally developed\, and third-party AI models into digital pathology workflows.  \n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nExplore approaches for enabling AI model interoperability with HALO.  \nImport ONNX models into HALO and incorporate them into digital pathology analysis workflows.  \nExport HALO AI-developed models to ONNX for use in external Python-based workflows.  \nDescribe how the HALO API can connect containerized or externally deployed AI models with the HALO ecosystem. \n\n\n\n\nRegister Now\nPresenter\n\nDonald AllenProduct Manager\, HALO AIIndica Labs  \nDonald Allen earned his BS in Microbiology\, Immunology\, and Molecular Genetics from UCLA. He has over 5 years of experience in R&D with Dako/Agilent in the field of companion diagnostics. He is experienced in feasibility of Class III medical device development\, deployment of clinical trial assays to CROs\, and the development of manual scoring algorithms. Donald now works in the field of digital pathology and image analysis to combine his work experience and his passion for computers and technology. He joined Indica Labs as an Applications Scientist in 2017\, was promoted to a Sr. Applications Scientist in 2020\, and most recently was promoted to the role of HALO AI Product Manager.  
URL:https://www.pathologynews.com/event/open-ai-workflows-in-digital-pathology-model-interoperability-with-halo/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/10/Open-AI-Workflows-in-Digital-Pathology-Model-Interoperability-with-HALO®.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T083000
DTEND;TZID=Europe/London:20261104T183000
DTSTAMP:20260923T143916Z
CREATED:20251013T111408Z
LAST-MODIFIED:20260923T143916Z
UID:100116144-1793781000-1793817000@www.pathologynews.com
SUMMARY:Path360 2026: The Convenzis NHS Pathology Strategy Conference Midlands
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nPathology services are integral to the NHS\, supporting over 70% of clinical diagnoses. As demands on pathology continue to grow\, innovation in digital pathology\, automation\, and workforce management is essential. This conference will explore the latest advancements and strategies for ensuring efficiency\, accuracy\, and service sustainability. \nKey Topics:\n\nDigital pathology and AI-driven diagnostics\nAddressing staff shortages and training needs\nThe future of pathology networks\nImproving turnaround times and service integration\nInvestment and funding for pathology services\n\nNHS Delegate RegistrationPrivate Delegate Registration\nRegister and use discount code\nPRNEWS10\nto receive 10% off your registration.\nWhy Attend?\nThis annual event brings together NHS pathology professionals\, laboratory managers\, and clinical leaders to explore cutting-edge developments in diagnostics. Join the conversation and be part of shaping the future of pathology services.
URL:https://www.pathologynews.com/event/pathvision-2026-the-convenzis-nhs-pathology-strategy-conference-midlands/
LOCATION:The Studio\, 3rd Floor\, Birmingham\, 3rd Floor\, 7 Cannon St\, Birmingham\, B2 5EP\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/PathVision-2026-The-Convenzis-NHS-Pathology-Strategy-Conference-Midlands.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261106
DTSTAMP:20260316T225057Z
CREATED:20260316T225057Z
LAST-MODIFIED:20260316T225057Z
UID:100119544-1793750400-1793923199@www.pathologynews.com
SUMMARY:Med4Nexus Exhibition & Summit UK 2026
DESCRIPTION:0000Days00Hrs00Min00SecWhere Biotech\, AI\, Digital Health & Connected Care Converge\nThe integrated healthcare event tracing the complete patient pathway\, from molecular diagnostics through clinical intelligence to targeted treatment. \nOver two days\, connect with 2\,500+ NHS decision-makers\, laboratory directors\, digital health executives\, clinicians\, academia\, pathologists\, biopharma leaders and investors. \nHealthcare is at a pivotal moment. Innovation in biotechnology\, AI\, digital health\, and connected care is converging amid rapid system digitisation\, growing investment\, and workforce pressures. Med4Nexus provides the platform where healthcare leaders\, laboratories\, and innovators collaborate to share insight and accelerate technologies that deliver real-world impact for patients and providers. \nRegister NowConference Themes & Format\nAt the heart of Med4Nexus Exhibition & Summit is a CPD-accredited conference programme featuring a main stage\, breakout sessions and specialist side events\, all designed to examine how new tools\, diagnostics\, digital platforms and therapeutic innovations perform within real clinical environments. The programme focuses on how innovation enhances patient outcomes\, strengthens diagnostic pathways\, streamlines operational performance and supports service redesign; bridging the gap between emerging solutions and real-world implementation across the NHS.
URL:https://www.pathologynews.com/event/med4nexus-exhibition-summit-uk-2026/
LOCATION:QEII Centre\, London\, UK\, London\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/Med4Nexus-Exhibition-Summit-UK-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20261103T160000
DTEND;TZID=UTC:20261103T170000
DTSTAMP:20261005T093820Z
CREATED:20260923T143618Z
LAST-MODIFIED:20261005T093820Z
UID:100125465-1793721600-1793725200@www.pathologynews.com
SUMMARY:Advances in Multimodal AI: de-risking drug development from discovery to CDx
DESCRIPTION:0000Days00Hrs00Min00SecLIVE PANEL featuring speakers from Amgen\, Regeneron\, & Modella AI / AstraZeneca\nThe latest generation of cancer therapies\, including antibody-drug conjugates and bispecifics\, is testing the limits of biomarker strategies\, and success depends on far more than target expression at the cell. The tumor microenvironment\, spatial biology and cancer cells morphological changes matter just as much\, sometimes shaping how a therapy or payload actually works. Yet these signals are extremely hard to quantify by conventional pathology and can be easily missed. \nAI-powered digital pathology and multimodal approaches are beginning to change that across stratification\, biomarker discovery\, and response monitoring: surfacing which H&E and IHC features are genuinely predictive\, making existing biomarker scoring more robust and reproducible\, and unlocking exploratory readouts that cannot be produced manually. \nThe field is maturing from promise to practice\, and this panel of experts will assess where it stands today. The panel will examine where AI digital pathology and multimodal models are already delivering measurable value and where they are still developing. They will explore the standard that translational teams set before trusting an AI-derived biomarker and ask what it really takes to move from a working model to a clinically deployable test\, and ultimately a companion diagnostic. \nKey learnings: \n\nWhere AI on H&E and IHC is delivering measurable value in drug development today\, and where it is still maturing.\nHow digital pathology is being applied across ADCs\, IO\, and bispecifics for stratification\, biomarker discovery\, and response monitoring.\nThe bar pharma translational teams set before trusting an AI-derived biomarker: robustness\, reproducibility\, regulatory readiness\, clinically deployable test\, including the CDx path.\n\nRegister NowMeriem Sefta\,\nCEO & Co-founder\,\nWaiv \nMeriem Sefta is Co-founder and Chief Executive Officer of Waiv\, where she sets the company’s scientific and strategic direction. She holds a PhD in computational and cancer biology from Institut Curie\, as well as a dual master’s in engineering from MIT and Polytechnique\, bringing a combined engineering and research background rooted in the molecular biology of cancer. She built and led the diagnostics business at Owkin\, which spun out as Waiv in 2026 with $35 million in financing co-led by OTB Ventures and Alpha Intelligence Capital. As CEO\, she drives Waiv’s mission to turn digital pathology and multimodal clinical data into clinically validated precision tests that improve outcomes for cancer patients worldwide. \nMike Montalto\,\nVice President of Precision Medicine\,\nAmgen \nMike Montalto\, Ph.D.\, is Vice President of Precision Medicine at Amgen\, where he leads efforts to advance biomarker-driven approaches that help inform drug development across the continuum of drug development from early stage discovery through registrational clinical trials\, across all therapeutic areas. He is an industry leader in translational and precision medicine\, digital pathology and the application of AI to biomarker discovery. Prior to joining Amgen\, Dr. Montalto served as Chief Scientific Officer at PathAI and Vice President of Translational Sciences at Bristol Myers Squibb\, where he led teams advancing biomarker science\, digital pathology\, and AI-enabled approaches. Dr. Montalto serves on the Executive Committee of the FNIH Biomarkers Consortium and the editorial board of the Journal of AI in Precision Oncology and is a member of the Friends of Cancer Research Digital Pathology and AutoRECIST Working Groups. He is also a former President and board member of the Digital Pathology Association. \nJill Stefanelli\, PhD\nPresident & CEO\,\nModella AI (a member of the AstraZeneca Group) \nJill Stefanelli\, PhD is a Cofounder and CEO of Modella AI\, recently acquired by AstraZeneca. Prior to Modella AI\, Jill served as the President\, Board Member\, and Chief Business Officer of Paige AI\, where she led the company’s strategic partnerships with life science companies and biomarker strategy in pathology. Prior to that\, Jill also served as the Senior Vice President and Head of Partnerships at Invitae / ArcherDX\, where she led the global Companion Diagnostic partnerships and alliances with pharmaceutical companies. \nJill’s experiences also include serving as the Clinical Commercial Development Lead at Life Technologies\, Genomics Specialist at Roche Diagnostics\, and in science and microbiology roles with USDA APHIS and Sandia National Laboratories. Jill obtained her Ph.D. in Molecular Medicine and Diagnostic Pathology at the College of Veterinary Medicine\, Kansas State University. \nJennifer Davidson Hamilton\,\nVP & Head\, Precision Medicine\,\nRegeneron \nJennifer Davidson Hamilton\, Ph.D.  is Vice President and Head\, Precision Medicine at Regeneron Pharmaceuticals\, Inc. Dr. Hamilton has over 25+ years of research and development experience in the biopharmaceutical industry.  She leads a team of specialists in Biomarker Sciences (including digital sensor-based technologies)\, Clinical Laboratory Operations\, Bioanalytical Quality and Clinical Diagnostics; applying Biomarker and Precision Medicine strategies across all therapeutics areas and modalities through all phases of development.
URL:https://www.pathologynews.com/event/from-biomarker-signal-to-clinical-decision-pharma-leaders-on-where-ai-pathology-actually-delivers-in-drug-development/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/1-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261103
DTEND;VALUE=DATE:20261104
DTSTAMP:20260714T092505Z
CREATED:20260316T215632Z
LAST-MODIFIED:20260714T092505Z
UID:100119528-1793664000-1793750399@www.pathologynews.com
SUMMARY:UK NEQAS Annual Participant Meeting 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe UK NEQAS CPT Annual Participant Meeting brings together cellular pathology professionals\, laboratory scientists\, and quality assurance experts to explore the latest developments in external quality assessment (EQA)\, laboratory best practice\, and diagnostic innovation. The meeting provides an opportunity for participants to hear updates from the UK NEQAS CPT team\, learn about emerging techniques and technologies\, and gain practical insights from keynote speakers working across the field of cellular pathology. \nAlongside the scientific programme\, the event encourages discussion\, knowledge sharing\, and networking between laboratories\, industry partners\, and healthcare professionals\, supporting continuous professional development and the ongoing improvement of quality standards in diagnostic pathology. \nRegister Now
URL:https://www.pathologynews.com/event/uk-neqas-annual-participant-meeting-2026/
LOCATION:America Square\, London\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/UK-NEQAS-Annual-Participant-Meeting-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261101
DTEND;VALUE=DATE:20261104
DTSTAMP:20260714T091833Z
CREATED:20260106T140532Z
LAST-MODIFIED:20260714T091833Z
UID:100117692-1793491200-1793750399@www.pathologynews.com
SUMMARY:ASDP 2026 Singapore | Asian Society of Digital Pathology 3rd Annual Congress
DESCRIPTION:0000Days00Hrs00Min00SecBringing together forward-thinking pathologists\, researchers\, healthcare executives\, and solution providers from across Asia and beyond – hosted in Singapore in November 2026. \nIntelligence in Every Pixel: Powering Next Generation Pathology \nAnnual Congress of the Asian Society of Digital Pathology (ASDP) serves as a unique platform where leaders in digital pathology\, computational science\, clinical practice\, and industry innovation converge. \nBuilding on the success of the first congress in Seoul (2024) and the second congress in Mumbai (2025)\, the third congress in Singapore in 2026 will bring together pathologists\, computer scientists\, researchers\, industry and policy makers from across the world to explore the latest advances in digital pathology\, artificial intelligence\, computational imaging and precision diagnostics. \nRegister NowASDP 2026 is proudly hosted by the Singapore Division of the International Academy of Pathology (SGIAP) and SingHealth Pathology Academic Clinical Programme (SingHealth PATH ACP).
URL:https://www.pathologynews.com/event/asdp-2026-singapore-asian-society-of-digital-pathology-3rd-annual-congress/
LOCATION:Academia\, Singapore General Hospital\, 20 College Rd\, Singapore\, 169856\, Singapore
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/ASDP-2026-Singapore-Asian-Society-of-Digital-Pathology-3rd-Annual-Congress.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261029
DTEND;VALUE=DATE:20261101
DTSTAMP:20260703T150450Z
CREATED:20260703T150450Z
LAST-MODIFIED:20260703T150450Z
UID:100122849-1793232000-1793491199@www.pathologynews.com
SUMMARY:ESOI Touchdown 2026
DESCRIPTION:0000Days00Hrs00Min00Sec\nESOI Touchdown 2026 brings together radiologists\, clinicians\, scientists\, patients\, and industry partners\, the meeting will explore the latest advances in oncologic imaging. \nThe scientific programme will cover a wide range of topics\, including artificial intelligence\, innovative imaging strategies\, multidisciplinary cancer care\, cancer screening\, therapy-related toxicities\, and the future of oncologic reporting. Alongside expert presentations\, attendees can take part in interactive workshops and multidisciplinary case discussions\, providing valuable opportunities for practical learning\, collaboration\, and networking within the international oncology imaging community. \n\nRegister Now\n\n\nHighlights\n\nSignal to Decision: How AI Is Transforming Radiology into the Engine of Integrated Oncologic Diagnostics\nKeynote Lecture: Individualising Oncologic Diagnostics: The Transformative Power of Liquid Biopsy\nCancer of Unknown Primary – Imaging at the Diagnostic Frontier\nStop Writing Novels: The Future of Radiology Reporting\nBridging Science and Care: Partnership of Patients\, Clinicians and Scientists\nNeuroendocrine Tumors\nInnovations in Cancer Screening\nDark side of the Treatment: Imaging Toxicities of Contemporary Cancer Therapy\n\n\n\n\n\n\n\nMDT Sessions\n\nLung Cancer MDT\nUrogenital Cancer MDT\nGynecological Oncology MDT\n\nWorkshops\n\nMRI Characterization of Ovarian Masses\nBone Metastasis & Their Mimics\nImaging in Hematologic Malignancies\nPatient Communication for Radiologists\nPrimary Liver Malignancies: Imaging for Detection and Treatment Planning\nChallenges in Head & Neck Imaging\nProstate Cancer: From PI-RADS to Individualized Care\nCommunication of Scientific Results: How to present yourself
URL:https://www.pathologynews.com/event/esoi-touchdown-2026/
LOCATION:DKFZ Heidelberg\, Im Neuenheimer Feld 280\, Heidelberg\, 69120\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/ESOI-Touchdown-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261028T170000
DTEND;TZID=Europe/London:20261028T180000
DTSTAMP:20260929T090015Z
CREATED:20260925T145017Z
LAST-MODIFIED:20260929T090015Z
UID:100125556-1793206800-1793210400@www.pathologynews.com
SUMMARY:Scaling Digital Pathology Through Innovation and Efficiency\, Not Additional Headcount
DESCRIPTION:0000Days00Hrs00Min00SecHNL Lab Medicine shares a practical approach to scaling digital pathology across a growing network without creating a separate digital department. The discussion will explore how HNL has expanded from telecytology to surgical pathology\, frozen section\, and additional cytology workflows by matching technology to specific clinical needs and integrating it into existing teams. Attendees will hear real-world lessons on workflow design\, staffing\, training\, connectivity\, remote review\, and how digital pathology can improve access to expertise\, collaboration\, and operational flexibility. \nLearning Objectives\n\nDifferentiate centralized high-throughput and distributed point-of-care digital pathology workflows and their operational value.\nIdentify ways to extend pathology and cytology coverage across locations without onsite specialists at every site.\nDescribe key workflow\, training\, connectivity\, communication\, and validation needs for digital frozen section and ROSE.\nEvaluate lower-volume\, high-impact digital pathology applications based on access\, turnaround time\, collaboration\, staffing flexibility\, and service expansion.\n\nRegister NowPresenters\nKelly Frankenfield\, MBA\, BSCT (ASCP)\nVice President of Pathology Operations\nHNL Lab Medicine \nKelly Frankenfield\, MBA\, currently serves as Vice President of Pathology Operations\, overseeing cytology\, histology\, gross rooms\, and administrative staff. Kelly earned her Bachelor of Science in Cytology from Thomas Jefferson University and her Master of Business Administration with a specialization in Healthcare Management from Fitchburg State University. She also holds a CT (ASCP) certification. \nElizabeth Moy\, MHS\, PA(ASCP)\nPathologists’ Assistant\nHNL Lab Medicine \nElizabeth Moy\, MHS\, PA(ASCP)\, is a Certified Pathologists’ Assistant with more than 15 years of surgical pathology experience. She earned her Master’s degree from Drexel University and has worked at URMC Highland Hospital\, Guthrie Robert Packer Hospital\, and HNL Lab Medicine\, where she has spent the past nine years. Her expertise includes specimen accessioning\, laboratory information systems (LIS)\, gross examination of routine and complex specimens\, intraoperative consultations\, quality control\, and gross room operations. Having worked in both community hospitals and large healthcare networks\, Elizabeth brings a broad range of experience and a strong commitment to quality patient care. \nSajjad Masood Malik\, MD\nMedical Director of Digital Pathology\nHNL Lab Medicine \nDr. Sajjad Malik is Medical Director of Digital Pathology at HNL Lab Medicine and a board-certified anatomic and clinical pathologist. He earned his MD from Drexel University College of Medicine\, completed his AP/CP residency at Thomas Jefferson University Hospital\, where he served as chief resident\, and completed a surgical pathology fellowship at Fox Chase Cancer Center. Dr. Malik has played a central role in HNL’s implementation and expansion of digital pathology and brings a clinical perspective on remote review\, collaboration\, workflow transformation\, and emerging AI applications.
URL:https://www.pathologynews.com/event/scaling-digital-pathology-through-innovation-and-efficiency-not-additional-headcount/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/09/1-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260702T140642Z
CREATED:20260702T140642Z
LAST-MODIFIED:20260702T140642Z
UID:100122818-1792713600-1793145599@www.pathologynews.com
SUMMARY:ESMO Congress 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world.\nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. \nParticipants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nRegister NowA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives\n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy
URL:https://www.pathologynews.com/event/esmo-congress-2026/
LOCATION:IFEMA MADRID\, Avda. Del Partenón\, 5\, Madrid\, 28042\, Spain
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/ESMO-Congress-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261016
DTEND;VALUE=DATE:20261019
DTSTAMP:20260714T085349Z
CREATED:20260109T114705Z
LAST-MODIFIED:20260714T085349Z
UID:100117809-1792108800-1792367999@www.pathologynews.com
SUMMARY:Pathology Visions 26
DESCRIPTION:0000Days00Hrs00Min00SecElevate Patient Care: Discover the Power of DP & AI\nPathology Visions unites 1\,000+ digital pathology experts and peers tackling today’s challenges and shaping tomorrow’s innovations. \nEngage in practical discussions\, explore real-world applications\, and gain actionable insights you can implement immediately. \nWhether you’re a seasoned expert or an emerging professional\, PathVisions offers a collaborative platform for learning and growth. \nDon’t just keep up with change\, lead it. Discover your place at PathVisions. \nRegister Now
URL:https://www.pathologynews.com/event/pathology-visions-26/
LOCATION:Manchester Grand Hyatt\, San Diego\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Pathology-Visions-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260826T121500Z
CREATED:20260812T081113Z
LAST-MODIFIED:20260826T121500Z
UID:100123977-1791849600-1792022399@www.pathologynews.com
SUMMARY:4th Spatial Biology Congress: Asia 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe 4th Spatial Biology Congress Asia brings together leaders in spatial biology\, imaging\, bioinformatics\, and multi-omics technologies to explore the latest methods and applications transforming biological insights and translational medicine. \nOver two days\, delegates will benefit from expert-led presentations\, panel discussions\, and interactive sessions focused on the latest innovations in spatial biology\, from high-plex imaging and complex datasets to cutting-edge analysis pipelines. The programme will also explore how these advances are supporting biomarker discovery\, disease research\, and clinical applications. \nWhy Attend?\n\n\n\n\nGain insights from leading researchers\, clinicians and industry innovators sharing the latest breakthroughs in the field of spatial biology\nExposure to the latest advances in spatial transcriptomics\, proteomics\, and imaging have transformed translational medicine\nCase studies demonstrating how spatial data informs disease stratification\, biomarker validation\, and clinical workflows\nConnect with fellow peers\, and solution providers through interactive sessions\, panel discussions\, and dedicated networking opportunities to foster collaboration\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/4th-spatial-biology-congress-asia-2026/
LOCATION:Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus)\, Singapore
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/08/4th-Spatial-Biology-Congress-Asia-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260710T110240Z
CREATED:20260710T110240Z
LAST-MODIFIED:20260710T110240Z
UID:100123101-1791849600-1792022399@www.pathologynews.com
SUMMARY:Biomarkers\, CDx & Precision Medicine Europe 2026
DESCRIPTION:0000Days00Hrs00Min00SecA new pathway to patient impact.\nTargeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments. \nAre you ready to participate in this shared opportunity? Do you have the knowledge\, strategy\, tools and connections in place? \nPrecision Medicine provides the platform for you to learn\, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma\, biotech\, academia and healthcare. \nThe event will feature three core programs: \n\nBiomarkers & Companion Diagnostics– Focusing on the discovery\, validation\, and application of biomarkers in personalized healthcare.\nSpatial Biology for Precision Medicine – Highlighting the importance of spatial insights in the development of precision therapies.\nComputational Pathology & AI for Precision Diagnostics– Exploring the integration of digital pathology and artificial intelligence in transforming clinical diagnostics.\n\nRegister Now\n\n\n\n\nWhy attend?\n\n\n\n\n\n\n\n\n\n\n\n\nExpand your knowledge\nLet subject specialists take you further and deeper.\nWith comprehensive learning in oncology\, neuroscience and key complementary areas. \nBuild the partnerships you need\nIdentify\, meet and collaborate with the people your strategy requires.\nStart working with those who share your goals with 200 hours of pre-arranged 1-2-1s. \nJoin the conversation\nMeet like-minded peers\, expand your network and engage in interdisciplinary discussion on the latest thinking and practice. \nSee what’s in the pipeline\nOur events are where innovations land.\nBe at the showcase and meet the people behind technologies to give you the edge. \nUnderstand the competitive landscape\nLearn what others in your field are doing.\nEvaluate their successes (and failures) and set your own benchmarks. \nHarness AI & machine learning\nAI & machine-learning tools will be critical in unlocking growth.\nSee the technology in action and speak to those who can help you implement it.
URL:https://www.pathologynews.com/event/biomarkers-cdx-precision-medicine-europe-2026/
LOCATION:Congress Center Basel\, Messeplatz 21\, Basel\, CH-4058\, Switzerland
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/Biomarkers-CDx-Precision-Medicine-Europe-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20261006T083000
DTEND;TZID=UTC:20261006T183000
DTSTAMP:20260907T130647Z
CREATED:20260205T142551Z
LAST-MODIFIED:20260907T130647Z
UID:100118525-1791275400-1791311400@www.pathologynews.com
SUMMARY:CancerCare 2026: The NHS Oncology Conference
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical SciencesA Strategic Conference on Advancing Oncology Pathways Across the NHS – All Convenzis Events Provide 8 CPD Points Per DelegateCancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis\, more equitable access to treatment\, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection\, innovation\, and personalisation at the heart of future oncology services. \nThe NHS Oncology Conference provides a strategic forum for leaders to address these challenges together\, translating policy ambition into practical delivery. This event brings NHS teams\, ICSs\, and cancer alliances together to exchange tested models\, frameworks\, and collaborative solutions to strengthen early detection\, scale genomics\, and integrate personalised oncology care within community settings. \nNHS Delegate RegistrationPrivate Delegate Registration\nRegister and use discount code\nPRNEWS10\nto receive 10% off your registration.\nSummit Focus:The NHS Oncology Conference is a premier event for sharing best practices and innovations\, designed to help NHS professionals move from awareness to applied implementation. Delegates will gain hands-on frameworks\, tested delivery models\, and peer-derived insights on how to embed safe\, equitable\, and sustainable transformation within their services. \nDedicated Skill Clinics offer practical tools\, checklists\, and implementation templates to support cancer pathway redesign\, genomic testing integration\, and workforce capability development. \nLessons Learned Sessions provide candid reflections from NHS leaders on real-world challenges\, highlighting where implementation plans required adjustment and what delivered measurable results. \nThis is not a showcase of what to achieve\, but a skills exchange on how to achieve it\, translating national ambition into measurable improvement. \nThis year’s event is structured around clear outcomes. Delegates will leave understanding: \n\nEnhance early detection through targeted screening\, self-sampling\, and expanded genetic testing.\nAccelerate innovation by adopting technologies like cancer vaccines\, liquid biopsies\, and whole genome sequencing.\nAdvance personalised care using genomics and AI to guide tailored treatments.\nExpand community-based oncology\, integrating diagnostics\, rehab\, and follow-up care into local health centres.\nStrengthen resilience through digital transformation\, workforce capability\, and robust governance.\nImprove access and equity across cancer pathways\, including prostate cancer and haematology services.\n\nWhat’s New for 2026:\nMorning & Afternoon Skill Clinics: immersive sessions focused on actionable tools\, checklists\, and templates delegates can implement immediately within oncology services.\nLessons Learned Sessions: real-world reflections from NHS leaders detailing what went wrong\, what changed\, and what succeeded in implementing cancer pathway transformation.\nPeer Learning Circles: small-group exchanges enabling collaboration between cancer alliances\, ICBs\, and provider teams to co-design practical solutions.\nAction-Driven Case Studies: focusing on the delivery process — how genomic testing\, data integration\, and workforce innovation created measurable outcomes.\n\nWhy Attend:\nEarn 8 CPD Points by attending.\nBuild professional confidence through applied\, hands-on learning.\nAccess ready-to-use frameworks for early detection\, genomic integration\, and pathway transformation.\nHear directly from NHS leaders and peers driving oncology service improvement.\nLeave with practical artefacts\, toolkits\, and implementation plans ready for local rollout.\nJoin a national community of NHS professionals committed to capability-building and sustainable cancer care delivery.\n\nWho Would Benefit:This conference is ideal for clinical\, operational\, and strategic leaders involved in oncology transformation\, including Cancer Alliance leads\, oncology service managers\, diagnostic and genomic programme directors\, Chief Nurses\, CCIOs\, CIOs\, AHP leads\, and ICB or ICS transformation teams. It will also benefit commissioners\, community health directors\, and primary care leaders seeking practical guidance on scalable\, interoperable models of cancer care. \nSuppliers\, research partners\, and technology collaborators will gain insight into NHS oncology priorities\, workforce capability needs\, and the practical enablers shaping the next decade of personalised cancer care.
URL:https://www.pathologynews.com/event/cancercare-2026-the-nhs-oncology-conference/
LOCATION:etc.venues\, Prospero House\, London\, 241 Borough High St\, London\, SE1 1GA\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/CancerCare-2026-The-NHS-Oncology-Conference.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20261006T083000
DTEND;TZID=UTC:20261006T183000
DTSTAMP:20260903T150908Z
CREATED:20251014T090032Z
LAST-MODIFIED:20260903T150908Z
UID:100116183-1791275400-1791311400@www.pathologynews.com
SUMMARY:CancerCare 2026: The Convenzis NHS Oncology Conference
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nA Learning-Focused Summit on NHS Oncology\nCancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis\, more equitable access to treatment\, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection\, innovation and personalisation at the heart of future oncology services. This summit responds directly to that call\, providing the education\, skills and tools NHS professionals need to deliver cancer care that is proactive\, personalised and closer to home. \nEducational Focus:\nThrough a mix of Skill Clinics\, Lessons Learned Sessions\, and Peer Learning Circles\, delegates will learn using real-world frameworks\, tools\, and templates to strengthen early detection pathways\, expand genomic testing\, and deliver community-based oncology care. \nThe focus is not on what to achieve\, but how to achieve it. Senior leaders and clinicians will share first-hand insights on implementation challenges\, course corrections and replicable improvement models that can be applied immediately within local systems. \nKey Topics:\n\nExpanding targeted screening\, self-sampling and early detection initiatives.\nScaling genomic testing and AI-guided personalised oncology care.\nIntegrating innovative technologies; including liquid biopsies\, cancer vaccines and whole genome sequencing\nRedesigning oncology pathways to deliver diagnostics\, rehabilitation and follow-up care within community settings.\nAccelerating treatment through digital integration\, data-driven coordination and insights from precision and immunotherapy trials.\n\nNHS Delegate RegistrationPrivate Delegate Registration\nRegister and use discount code\nPRNEWS10\nto receive 10% off your registration.\nWhat’s New for 2026:\n\nMorning and Afternoon Skill Clinics: immersive sessions providing delegates with practical templates for screening pathway redesign\, genomic testing workflows and community-based cancer care models.\nLessons Learned Sessions: senior NHS leaders share where implementation plans faced challenges and what changes delivered success.\nPeer Learning Circles: facilitated\, topic-specific discussions connecting oncology teams\, commissioners and innovation leads across the UK.\nAction-Driven Case Studies: focused on the how: methods\, processes and team structures that made progress possible.\n\nWhy Attend:\n\nBuild confidence through structured\, applied learning and guided skill development.\nGain access to replicable frameworks for early diagnosis\, genomic testing and localised cancer care delivery.\nHear directly from peers navigating similar workforce\, innovation and integration challenges.\nLeave with practical artefacts\, toolkits\, checklists and action plans ready to use within your organisation.\nStrengthen your professional network through collaborative learning and best practice sharing across regions and specialties.\n\nWho Would Benefit:\nThis summit is ideal for oncology service leads\, cancer nurse specialists\, diagnostic and genomic programme managers\, community health directors and primary care leaders working to deliver more personalised\, efficient and equitable cancer care. It will also benefit commissioners\, clinical directors and innovation leads seeking practical insight into how to scale early detection\, accelerate innovation and integrate cancer services into local care systems. \nSuppliers\, research partners and technology innovators will gain a clear understanding of the operational priorities shaping the next decade of NHS oncology transformation.
URL:https://www.pathologynews.com/event/cancercare-2026-the-convenzis-nhs-oncology-conference/
LOCATION:The Studio\, 3rd Floor\, Birmingham\, 3rd Floor\, 7 Cannon St\, Birmingham\, B2 5EP\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/CancerCare-2026-The-Convenzis-NHS-Oncology-Conference.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261005T000000
DTEND;TZID=America/New_York:20261008T000000
DTSTAMP:20260709T155448Z
CREATED:20260709T155448Z
LAST-MODIFIED:20260709T155448Z
UID:100123032-1791158400-1791417600@www.pathologynews.com
SUMMARY:16th Annual World CB & CDx Summit
DESCRIPTION:0000Days00Hrs00Min00SecAccelerating Complex Biomarkers\, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access \nAs regulatory headwinds turn to tailwinds\, precision medicine is shifting into a new gear. \nEvolving FDA approaches to LDTs and 510(k) pathways are removing long-standing friction\, coordinated Rx-Dx launches are gaining pace\, ctDNA and MRD are advancing as clinically meaningful endpoints\, and reimbursement expansion is improving access to high-value genomic testing. At the same time\, innovation in multiplex assays\, multi-omics platforms\, liquid biopsy\, digital pathology\, spatial biology\, and AI-powered diagnostics\, are rapidly reshaping the IVD landscape. \nFueled by $60B+ in diagnostic deal-making and strategic partnerships\, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns as the industry’s esteemed end-to-end precision medicine forum. Convening 850+ senior leaders from biopharma\, diagnostic\, regulatory\, healthcare\, testing labs and multimodal communities\, with expertise spanning the full value chain\, gain the insights\, partnerships and insider know-how to prime your team for continued clinical and commercial success. \nWith the race to bring scalable\, accessible drug-diagnostic programs from bench-to-bedside heating up\, join us in harnessing the speed\, scale\, and growing complexity of innovation happening in next-generation IVD platforms\, multimodal data\, and CDx development. \nRegister Now\n\n\n\n\nDelve into the Brand-New Agenda\n\n\n\n\n\n\n\n\n\n\n\n\nFree* Attendance for Representatives from Biopharma & Academia \nYour Globally Leading Biomarker & Companion Diagnostics Forum \nAccess Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels \nPartake in Multiple Biomarker Sessions Spanning Oncology\, Hematology & Neurological\, Chronic\, Autoimmune & Rare Diseases\nDiscover Brand-New Case Studies on Digital Pathology\, Multimodal Data & AI-Enabled Precision Medicine \nTake Advantage of Unmatched\, Exclusive Networking & Partnerships Opportunities 
URL:https://www.pathologynews.com/event/16th-annual-world-cb-cdx-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/16th-Annual-World-CB-CDx-Summit.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261003
DTEND;VALUE=DATE:20261007
DTSTAMP:20260316T222542Z
CREATED:20260316T222542Z
LAST-MODIFIED:20260316T222542Z
UID:100119537-1790985600-1791331199@www.pathologynews.com
SUMMARY:CAP 2026
DESCRIPTION:0000Days00Hrs00Min00SecCAP26 is where the future of pathology takes shape; where pathologists gather not just to gain knowledge\, but to exchange ideas\, build relationships\, and reconnect around a shared vision. \nThe conversations are real\, the education is practical\, and the sense of belonging is unmistakable. You’re among colleagues who understand the stakes\, the challenges\, and what it means to be truly focused on patient outcomes. \nRegister NowThe CAP26 Abstract Program is a competitive program sponsored by the College of American Pathologists (CAP). The program is designed to promote a broad range of research in pathology. It offers pathologists and research scientists the opportunity to present original research to their peers in a poster presentation format.
URL:https://www.pathologynews.com/event/cap-2026/
LOCATION:Wynn\, Las Vegas\, NV\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/CAP-2026.jpg
END:VEVENT
END:VCALENDAR